The United States will send medical assistance to India amid a recent surge of COVID-19 cases in the South Asian country, the White House announced on April 25.
“Just as India sent assistance to the United States as our hospitals were strained early in the pandemic, the United States is determined to help India in its time of need,” National Security Spokesperson Emily Horne said in a statement.
According to the statement, the U.S. will send raw materials required to manufacture the Covishield vaccine in India.
Furthermore, the U.S. Development Finance Corporation is funding “a substantial expansion” of manufacturing capability for Indian vaccine manufacturer Biological E to ramp up production of COVID-19 vaccine doses to at least one billion by the end of 2022, the statement said.
The statement also said that the U.S. will send supplies of therapeutics, rapid diagnostic test kits, ventilators, and personal protective equipment to India to help its medical workers and COVID-19 patients.
The U.S. is also looking into options to send oxygen generation and related supplies and will deploy a team of public health advisors from the Centers for Disease Control and USAID to collaborate closely with the Indian government, the statement said.
The pledge came during a phone call between U.S. National Security Advisor Jake Sullivan and Indian National Security Advisor Ajit Doval.
Other countries, including Singapore, Germany, and the United Kingdom, have also pledged to send medical aid to India.
The announcement came a day after India reported 346,000 new cases in a day — a new global record.
According to data from Johns Hopkins University (JHU), India has recorded 16,960,172 cases — the second highest in the world after the U.S. — since the pandemic began.
India has also recorded 192,311 deaths — the fourth highest in the world, according to JHU.
© Fourth Estate
® — All Rights Reserved.
This material may not be published, broadcast, rewritten or redistributed.